Understanding these mechanisms has facilitated the design of innovative treatments targeting this axis, including probiotics, dietary interventions, and FXR/TGR5-targeting drugs, which offer innovative approaches for preventing and treating metabolic disorders. This evidence concerns the gene GPBAR1 and metabolic disease.